Ποια είναι η τιμή για Dongwha Pharm.Co.,Ltd (000020)

Η τιμή για Dongwha Pharm.Co.,Ltd (000020) είναι $3.52

Ποια είναι η κεφαλαιοποίηση αγοράς για Dongwha Pharm.Co.,Ltd (000020)

Η κεφαλαιοποίηση αγοράς για Dongwha Pharm.Co.,Ltd (000020) είναι $97.56M

Dongwha Pharm.Co.,Ltd (000020) Τιμή και Κεφαλαιοποίηση Αγοράς

Dongwha Pharm Co., Ltd. is a South Korean entity primarily engaged in the production and distribution of pharmaceutical goods. The company's diverse offerings include prescription-only medications addressing a wide spectrum of health concerns such as digestive and infectious diseases, cardiovascular and metabolic disorders, inflammatory and respiratory conditions, musculoskeletal and neurological ailments, as well as dermatological and urological issues. Furthermore, they market an extensive selection of over-the-counter (OTC) remedies, covering categories like digestive aids, cold and flu treatments, anti-inflammatory and respiratory solutions, skin care, oral hygiene, liver support, nutritional supplements, tonics, topical pain relief, antihistamines, and remedies for sore throats, among other products. Beyond pharmaceuticals, Dongwha Pharm also ventures into quasi-drugs, health supplements, food and beverage items, and cosmetics. Established in 1897, the firm maintains its headquarters in Seoul, South Korea.

Η τιμή για 000020	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$188,015 $97.56M	NVDA	$5.211T	+5,341,691.08%
$164,037 $97.56M	AAPL	$4.547T	+4,660,435.01%
$150,173 $97.56M	GOOG	$4.162T	+4,266,548.06%
$129,620 $97.56M	MSFT	$3.593T	+3,682,605.61%
$100,760 $97.56M	AMZN	$2.793T	+2,862,649.62%

Η τιμή για 000020

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$188,015 $97.56M